This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2007 Sep 1;370(9589):738; author reply 738.

doi: 10.1016/S0140-6736(07)61370-1.

Heparin in sepsis treatment

Christoph Pechlaner, Michael Joannidis

PMID: 17765516
DOI: 10.1016/S0140-6736(07)61370-1

Comment

Heparin in sepsis treatment

Christoph Pechlaner et al. Lancet. 2007.

. 2007 Sep 1;370(9589):738; author reply 738.

doi: 10.1016/S0140-6736(07)61370-1.

Authors

Christoph Pechlaner, Michael Joannidis

PMID: 17765516
DOI: 10.1016/S0140-6736(07)61370-1

No abstract available

PubMed Disclaimer

Comment on

Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial.
Nadel S, Goldstein B, Williams MD, Dalton H, Peters M, Macias WL, Abd-Allah SA, Levy H, Angle R, Wang D, Sundin DP, Giroir B; REsearching severe Sepsis and Organ dysfunction in children: a gLobal perspective (RESOLVE) study group. Nadel S, et al. Lancet. 2007 Mar 10;369(9564):836-843. doi: 10.1016/S0140-6736(07)60411-5. Lancet. 2007. PMID: 17350452 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information